Investigating how lymphatics affect muscle health in Duchenne muscular dystrophy
Role of Skeletal Muscle Lymphatics in Duchenne Muscular Dystrophy Regulation
This study is looking at how improving the lymphatic system might help reduce inflammation and boost muscle health in people with Duchenne muscular dystrophy (DMD), with hopes of finding new treatments to make life better for those affected by this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas A&m University Health Science Ctr NIH-funded |
| Lab location | 1 site (College Station, United States) |
| Project ID | NIH-11067785 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of lymphatic vessels in Duchenne muscular dystrophy (DMD), a severe muscle-wasting disease. The study aims to explore how enhancing lymphatic function can reduce inflammation and improve muscle health in affected individuals. By examining animal models, researchers will investigate the mechanisms behind lymphangiogenesis and its potential to promote muscle healing. The ultimate goal is to develop new therapeutic strategies that could lead to better outcomes for patients with DMD.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Duchenne muscular dystrophy, particularly those experiencing significant muscle weakness and inflammation.
Not a fit: Patients with other forms of muscular dystrophy or those without significant muscle inflammation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments that improve muscle function and reduce inflammation in patients with Duchenne muscular dystrophy.
How similar studies have performed: Previous research has shown promising results in using lymphatic modulation to improve muscle health, indicating that this approach may be viable for treating DMD.
Where this research is happening
College Station, United States
- Texas A&m University Health Science Ctr — College Station, United States (Active)
Researchers
- Principal investigator: Muthuchamy, Mariappan — Texas A&m University Health Science Ctr
- Study coordinator: Muthuchamy, Mariappan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.